Inhibitors of Human EZH2 and Methods of Use Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/381,684, filed Sep 10, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,175,331 | Inhibitors of Human EZH2, and Methods of Use Thereof In force · Medium confidence UsedRemaining | Epizyme, Inc. | In force | Medium confidence | ||
| US 9,333,217 | Inhibitors of Human EZH2, and Methods of Use Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| US 9,334,527 | Inhibitors of Human EZH2, and Methods of Use Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| US 9,949,999 | Inhibitors of Human EZH2, and Methods of Use Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| US 8,691,507 | Inhibitors of Human EZH2 and Methods of Use Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| US 8,895,245 | Inhibitors of Human EZH2 and Methods of Use Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| Application 15/132,610 | Inhibitors of Human EZH2, and Methods of Use Thereof Abandoned Abandoned Nov 9, 2017 | Epizyme, Inc. | Abandoned | Abandoned Nov 9, 2017 | ||
| Application 15/800,983 | Inhibitors of Human EZH2, and Methods of Use Thereof Abandoned Abandoned Oct 29, 2019 | Epizyme, Inc. | Abandoned | Abandoned Oct 29, 2019 | ||
| Application 15/924,663 | Inhibitors of Human EZH2, and Methods of Use Thereof Abandoned Abandoned Jul 14, 2020 | Epizyme, Inc. | Abandoned | Abandoned Jul 14, 2020 | ||
| Application 16/453,501 | Inhibitors of Human EZH2, and Methods of Use Thereof Abandoned Abandoned Jun 12, 2024 | Epizyme, Inc. | Abandoned | Abandoned Jun 12, 2024 | ||
| 1 more record in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
6 of these are in force and held by Epizyme, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.